Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adenosine and Purinergic Signaling
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the molecular physiology and pharmacology of purinergic signalling, including the role of adenosine receptors, P2X receptors, and nucleotide signalling in immune suppression, inflammation, neuroprotection, and the tumor microenvironment. It explores the potential therapeutic targets related to purinergic signalling.
157
Works
IDs:OpenAlex
How has Adenosine and Purinergic Signaling's publication output changed over time?
ScholarIQpublication output · 2001–2020
Output declined50% over the shown period — from 2 works in 2001 to 1 in 2020.
2
3
1
3
1
1
1
1
1
1
2001200220042005200720102011201420172020
What are the most-cited papers on Adenosine and Purinergic Signaling?
ScholarIQmost cited works
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
Louise Arseneault, Mary Cannon, R. Poulton, Robin Murray, Avshalom Caspi, Terrie E. Moffitt
BMJ. 20021,408 CitationsOPEN ACCESS
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression
Giovanna Borsellino, Markus Kleinewietfeld, Diletta Di Mitri, Alexander Sternjak, Adamo Diamantini, Raffaella Giometto, Sabine Höpner, Diego Centonze, Giorgio Bernardi, Maria Luisa Dell’Acqua, Paolo Maria Rossini, Luca Battistini, Olaf Rötzschke, Kirsten Falk
Blood. 20071,263 CitationsOPEN ACCESS
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
Faraaz B. Chekeni, Michael R. Elliott, Joanna K. Sandilos, Scott F. Walk, Jason M. Kinchen, Eduardo R. Lazarowski, Allison J. Armstrong, Silvia Peñuela, Dale W. Laird, Guy S. Salvesen, Brant E. Isakson, Douglas A. Bayliss, Kodi S. Ravichandran
Nature. 20101,114 Citations
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
Qing Zhou, Dan Yang, Amanda K. Ombrello, Andrey V. Zavialov, Camilo Toro, Anton V. Zavialov, Deborah L. Stone, Jae Jin Chae, Sergio D. Rosenzweig, Kevin Bishop, Karyl S. Barron, Hye Sun Kuehn, Patrycja Hoffmann, Alejandra Negro, Wanxia Li Tsai, Edward W. Cowen, Wuhong Pei, Joshua D. Milner, Christopher Silvin, Theo Heller, David T. Chin, Nicholas J. Patronas, John S. Barber, Chyi‐Chia Richard Lee, Geryl Wood, Alexander Ling, Susan J. Kelly, David E. Kleiner, James C. Mullikin, Nancy J. Ganson, Heidi H. Kong, Sophie Hambleton, Fabio Candotti, Martha Quezado, Katherine R. Calvo, Hawwa Alao, Beverly Barham, Anne Jones, James F. Meschia, Bradford B. Worrall, Scott E. Kasner, Stephen S. Rich, Raphaela Goldbach‐Mansky, Mario Abinun, Elizabeth Chalom, Alisa Gotte, Marilynn Punaro, Virginia Pascual, James Verbsky, Troy R. Torgerson, Nora G. Singer, Timothy R. Gershon, Seza Özen, Ömer Karadağ, Thomas A. Fleisher, Elaine F. Remmers, Shawn M. Burgess, Susan Moir, Massimo Gadina, Raman Sood, Michael S. Hershfield, Manfred Boehm, Daniel L. Kastner, Ivona Aksentijevich
New England Journal of Medicine. 2014902 CitationsOPEN ACCESS
Innate immunity in diabetic kidney disease
Sydney Tang, Wai Han Yiu
Nature Reviews Nephrology. 2020611 Citations
Where is Adenosine and Purinergic Signaling research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Adenosine and Purinergic Signaling is open access?
ScholarIQopen access share
40%OPEN ACCESS
Gold
0%
Green
20%
Hybrid
7%
Bronze
13%
Closed
60%
Related on ScholarIQ
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
Paper
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression
Paper
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
Paper
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
Paper
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Paper
(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Paper